Variation der Alkaloidmengen in Fruchtkörpern vonInocybe aeruginascens
Planta Medica December 1, 1987 DOI: 10.1055/s-2006-962805 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational study Peer reviewed |
|---|---|
| Population | Inocybe aeruginascens mushrooms |
| Topics | Psilocybin |
| Citations | 20 |
| Key findings | The psilocybin and baeocystin content in Inocybe aeruginascens varies among individuals but is strongly correlated with each other, and not related to mushroom mass or collection location. |
Abstract
INOCYBE AERUGINASCENS contains psilocybin, baeocystin, and aeruginascin with a still unknown structure in the caps and the stipes. The content of psilocybin and baeocystin has been investigated. The psilocybin and baeocystin content of mushrooms from the same location and with similar mass varied. No correlation has been found between the mass of the mushrooms and the content of psilocybin and baeocystin. There was an extensive correlation between the content of psilocybin and baeocystin. No relation between the location and the content of the indole derivatives seems to exist.
Comparable studies
Other observational and cohort studies on psilocybin, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms. Patients with treatment-resistant depression | 2017 | Observational cohort | n = 19 |
| Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels Healthy volunteers | 2019 | Observational cohort | n = 8 |
| Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin Humans | 2017 | Observational study | |
| Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. USA adult respondents from the National Survey on Drug Use and Health (2008-2012) | 2015 | Observational cohort | n = 190,000 |
| Prediction of Psilocybin Response in Healthy Volunteers Healthy volunteers | 2012 | Observational cohort | n = 409 |
Citations in the library
Cited by 10
- The Therapeutic Potential of Psilocybin Molecules May 15, 2021
- Structure–Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice ACS Pharmacology & Translational Science November 2, 2022
- Synthesis and Biological Evaluation of Tryptamines Found in Hallucinogenic Mushrooms: Norbaeocystin, Baeocystin, Norpsilocin, and Aeruginascin Journal of Natural Products February 20, 2020
- Aeruginascin, a Trimethylammonium Analogue of Psilocybin from the Hallucinogenic MushroomInocybe aeruginascens Planta Medica April 1, 2006
- Occurrence and use of hallucinogenic mushrooms containing psilocybin alkaloids TemaNord May 19, 2009
and 5 more in the library